HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Pazo-Cid Selected Research

Cytokines

12/2022Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Pazo-Cid Research Topics

Disease

10Adenocarcinoma
02/2024 - 01/2016
10Neoplasms (Cancer)
12/2023 - 05/2016
8Pancreatic Neoplasms (Pancreatic Cancer)
02/2024 - 01/2016
5Stomach Neoplasms (Stomach Cancer)
12/2023 - 12/2013
2Disease Progression
01/2023 - 01/2022
2Breast Neoplasms (Breast Cancer)
01/2018 - 01/2013
1Neutropenia
02/2024
1Thrombocytopenia (Thrombopenia)
02/2024
1Neoplasm Metastasis (Metastasis)
01/2023
1Esophageal Squamous Cell Carcinoma
10/2022
1Microsatellite Instability
01/2022
1Exanthema (Rash)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2016
1Infections
09/2015
1Duodenal Ulcer (Curling's Ulcer)
09/2015
1Cardiotoxicity
01/2013

Drug/Important Bio-Agent (IBA)

6GemcitabineFDA Link
02/2024 - 01/2016
5NivolumabIBA
02/2024 - 01/2021
4human ERBB2 proteinIBA
12/2023 - 01/2021
4Biomarkers (Surrogate Marker)IBA
04/2023 - 01/2022
3130-nm albumin-bound paclitaxelIBA
02/2024 - 01/2019
3Trastuzumab (Herceptin)FDA Link
01/2018 - 01/2013
2Fluorouracil (Carac)FDA LinkGeneric
02/2024 - 01/2023
2Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2024 - 01/2023
2Leucovorin (Folinic Acid)FDA Link
02/2024 - 01/2023
2AntigensIBA
12/2022 - 09/2015
2B7-H1 AntigenIBA
10/2022 - 01/2022
2LigandsIBA
01/2021 - 05/2016
2IMM-101IBA
10/2016 - 01/2016
1NitrogenIBA
04/2023
1AminesIBA
04/2023
1zolbetuximabIBA
01/2023
1Monoclonal AntibodiesIBA
01/2023
1Protein Isoforms (Isoforms)IBA
01/2023
1ElementsIBA
12/2022
1Piwi-Interacting RNAIBA
12/2022
1Proteins (Proteins, Gene)FDA Link
12/2022
1CarbohydratesIBA
12/2022
1CytokinesIBA
12/2022
1Tissue Inhibitor of Metalloproteinase-1IBA
12/2022
1Chemokine CCL5IBA
12/2022
1Interleukin-10 (Interleukin 10)IBA
12/2022
1tislelizumabIBA
10/2022
1Irinotecan (Camptosar)FDA LinkGeneric
10/2022
1Programmed Cell Death 1 ReceptorIBA
10/2022
1Docetaxel (Taxotere)FDA Link
10/2022
1Paclitaxel (Taxol)FDA LinkGeneric
10/2022
1IpilimumabIBA
01/2022
1PolymersIBA
06/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1AlbuminsIBA
01/2019
1Albumin-Bound PaclitaxelFDA Link
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018
1Capecitabine (Xeloda)FDA Link
01/2017
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2017
1A-Form DNA (A-DNA)IBA
10/2016
1alvocidib (flavopiridol)IBA
05/2016
1N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
05/2016
1Lipid NanoparticlesIBA
05/2016
1liposomal doxorubicin (Doxil)FDA Link
01/2013
1AnthracyclinesIBA
01/2013

Therapy/Procedure

7Drug Therapy (Chemotherapy)
02/2024 - 12/2013
5Therapeutics
12/2023 - 01/2013
2Immunotherapy
04/2023 - 01/2022
1Combination Drug Therapy (Combination Chemotherapy)
04/2023
1Gastrectomy
01/2023
1Lab-On-A-Chip Devices
10/2020